Kinarus Therapeutics Holding AG – SIX:PRFN.SW

Add to watchlist

CHF 0.079

+0.04

+161.67%

Market closed

Open in about 9 hours

-17.13%

month

-62.69%

quarter

-57.14%

year

Market Cap	N/A
Enterprise value	6.85M

P/E	-36.2
EV/Sales	0.40
EV/EBITDA	-8.24
Price/Sales	0.38
Price/Book	-16.38
PEG ratio	0.01
EPS	N/A

Revenue	17.02M
EBITDA	-831.75K
Income	-895.5K
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-5.26%
Oper. margin	-4.91%
Gross margin	4.82%
EBIT margin	-4.91%
EBITDA margin	-4.89%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Kinarus Therapeutics Holding AG (SIX:PRFN.SW): Profit margin
Jun 2018	4.04M	-190.5K	-4.71%
Jan 2019	4.32M	-235K	-5.43%
Mar 2019	4.32M	-235K	-5.43%
Jun 2019	4.32M	-235K	-5.43%

Kinarus Therapeutics Holding AG (SIX:PRFN.SW): Debt to assets
Jun 2020	214000	277K	129.44%
Dec 2020	127000	384K	302.36%
Jun 2021	181000	405K	223.76%
Dec 2021	136000	536K	394.12%

Kinarus Therapeutics Holding AG (SIX:PRFN.SW): Cash Flow
Jun 2018	-187.25K	-1K	4K
Jan 2019	-165.5K	149.25K	-5.75K
Mar 2019	-165.5K	149.25K	-5.75K
Jun 2019	-165.5K	149.25K	-5.75K

Kinarus Therapeutics Holding AG alternative data

Kinarus Therapeutics Holding AG
Employees

Kinarus Therapeutics Holding AG (SIX:PRFN.SW): Employee count
Aug 2023	15
Sep 2023	15
Oct 2023	15
Nov 2023	15
Dec 2023	15
Jan 2024	15
Feb 2024	15
Mar 2024	15
Apr 2024	15
May 2024	15
Jun 2024	15
Jul 2024	15

Frequently Asked Questions (FAQ)

What's the price of Kinarus Therapeutics Holding AG stock today?

One share of Kinarus Therapeutics Holding AG stock can currently be purchased for approximately $0.08.
When is Kinarus Therapeutics Holding AG's next earnings date?

Unfortunately, Kinarus Therapeutics Holding AG's (PRFN.SW) next earnings date is currently unknown.
Does Kinarus Therapeutics Holding AG pay dividends?

No, Kinarus Therapeutics Holding AG does not pay dividends.
What is Kinarus Therapeutics Holding AG's stock symbol?

Kinarus Therapeutics Holding AG is traded on the SIX under the ticker symbol "PRFN.SW".
What is Kinarus Therapeutics Holding AG's primary industry?

Company operates in the Industrials sector and Airlines, Airports & Air Services industry.
How do i buy shares of Kinarus Therapeutics Holding AG?

Shares of Kinarus Therapeutics Holding AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Kinarus Therapeutics Holding AG have?

As Jul 2024, Kinarus Therapeutics Holding AG employs 15 workers.
When Kinarus Therapeutics Holding AG went public?

Kinarus Therapeutics Holding AG is publicly traded company for more then 25 years since IPO on 18 Oct 1999.
What is Kinarus Therapeutics Holding AG's official website?

The official website for Kinarus Therapeutics Holding AG is kinarus.com.
Where are Kinarus Therapeutics Holding AG's headquarters?

Kinarus Therapeutics Holding AG is headquartered at Avenue de Florimont 3, Lausanne, VAUD.
How can i contact Kinarus Therapeutics Holding AG?

Kinarus Therapeutics Holding AG's mailing address is Avenue de Florimont 3, Lausanne, VAUD.

Kinarus Therapeutics Holding AG

kinarus.com

Exchange:

SIX

Full time employees:

Industry:

Airlines, Airports & Air Services

Sector:

Industrials

Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company is based in Lausanne, Switzerland.

Avenue de Florimont 3
Lausanne, VAUD 1006

:
ISIN: CH0009115129
CUSIP: H6132B105